CCM Duopharma Biotech Bhd | Cash Flow
Fiscal year is January-December. All values MYR Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
40,175.00
46,501.00
47,829.00
31,480.00
51,772.00
Depreciation, Depletion & Amortization
7,785.00
8,268.00
21,532.00
22,500.00
24,120.00
Other Funds
11,823.00
9,679.00
13,836.00
10,170.00
4,992.00
Funds from Operations
36,137.00
45,090.00
55,525.00
43,810.00
70,900.00
Changes in Working Capital
3,690.00
8,952.00
105,017.00
6,335.00
12,133.00
Net Operating Cash Flow
39,827.00
36,138.00
49,492.00
37,475.00
58,767.00
Capital Expenditures
8,842.00
12,427.00
41,417.00
34,683.00
74,589.00
Sale of Fixed Assets & Businesses
32.00
7.00
-
-
-
Net Investing Cash Flow
9,958.00
12,420.00
148,666.00
34,683.00
74,589.00
Cash Dividends Paid - Total
20,129.00
24,294.00
31,383.00
22,317.00
18,132.00
Issuance/Reduction of Debt, Net
5,000.00
-
103,668.00
9,460.00
14,143.00
Net Financing Cash Flow
25,129.00
24,294.00
324,087.00
31,777.00
3,989.00
Net Change in Cash
4,740.00
576.00
125,207.00
28,696.00
18,793.00
Free Cash Flow
30,985.00
23,711.00
89,496.00
3,216.00
10,545.00
Net Assets from Acquisitions
-
-
108,849.00
-
-
Other Sources
-
-
1,600.00
-
-
Change in Capital Stock
-
-
251,802.00
-
-
Exchange Rate Effect
-
-
722.00
289.00
1,018.00
Other Uses
1,148.00
-
-
-
-
About CCM Duopharma Biotech Bhd
View Profile
